List of SBIR/STTR awards granted to O-Ray pharma
O-Ray pharmaName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to O-Ray pharma in December, 2021 for $886,552.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI167132-01 | Phase II | 886,552 | December 22, 2021 | |||||||
A SBIR Phase I contract was awarded to O-Ray pharma in August, 2018 for $169,214.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DC017415-01 | Phase I | 169,214 | August 1, 2018 | |||||||
A SBIR Phase II contract was awarded to O-Ray pharma in April, 2020 for $284,456.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DC014416-04 | Phase II | 284,456 | April 8, 2020 | |||||||
A SBIR Phase II contract was awarded to O-Ray pharma in June, 2016 for $1,201,768.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DC014416-02 | Phase II | 1,201,768 | June 20, 2016 | |||||||
A SBIR Phase II contract was awarded to O-Ray pharma in June, 2014 for $1,337,994.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DC008477-04A1 | Phase II | 1,337,994 | June 9, 2014 | |||||||
A SBIR Phase I contract was awarded to O-Ray pharma in July, 2015 for $161,422.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DC014410-01A1 | Phase I | 161,422 | July 1, 2015 | |||||||
A SBIR Phase I contract was awarded to O-Ray pharma for $154,472.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DC012265-01A1 | Phase I | 154,472 | ||||||||
A SBIR Phase I contract was awarded to O-Ray pharma for $159,277.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DC014416-01 | Phase I | 159,277 | ||||||||
A SBIR Phase II contract was awarded to O-Ray pharma for $1,071,370.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DC008477-02 | Phase II | 1,071,370 | ||||||||
A SBIR Phase II contract was awarded to O-Ray pharma for $1,337,994.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DC008477-04A1 | Phase II | 1,337,994 |
